Estrogenic 17.alpha.-halogen-vinylestranes
    1.
    发明授权
    Estrogenic 17.alpha.-halogen-vinylestranes 失效
    雌激素17α-卤素 - 乙烯基甲苯

    公开(公告)号:US4725426A

    公开(公告)日:1988-02-16

    申请号:US758982

    申请日:1985-07-25

    摘要: 17.alpha.-bromo-.alpha. and 17.alpha.-iodo-vinyl-estrane derivatives of general formula I ##STR1## wherein X is a bromine or iodine atom in Z or E position,R.sup.1 is hydrogen, hydroxy or acyloxy with up to 3 C atoms,R.sup.2 is hydrogen, alkyl with up to 3 C atoms and alkanoyl and aroyl with up to 7 C atoms,R.sup.3 is hydrogen or methyl,R.sup.4 is a hydrogen atom in the .alpha. or .beta. position,R.sup.5 is hydrogen, methyl or methoxy andR.sup.6 is hydrogen or methyl,are pharmacologically effective with a profile of action like ethinylestradiol and in the form of their radioactively labeled compounds are also valuable diagnostic media.The Z-isomers can be prepared by a new process by reaction of the corresponding 17.alpha.-ethinyl steroids with trialkyl (or phenyl) tin hydride with addition of a free radical former.

    摘要翻译: 17α-α-α-和17α-碘代乙烯基 - 雌酮衍生物,其通式I(I)其中X是Z或E位上的溴或碘原子,R 1是氢,羟基或酰氧基,直到 3个C原子,R2是氢,具有高达3 C原子的烷基和具有多达7个C原子的烷酰基和芳酰基,R3是氢或甲基,R4是α或β位的氢原子,R5是氢,甲基或 甲氧基和R6是氢或甲基,在药理学上有效,其作用如炔雌醇,其放射性标记的化合物的形式也是有价值的诊断介质。 Z-异构体可以通过相应的17α-乙烯基类固醇与三烷基(或苯基)锡氢化物反应并通过加入自由基前体而通过新方法制备。

    Process for the preparation of 17.alpha.-bromoethynyl- and
17.alpha.-iodoethynyl-17.beta.-hydroxy steroids and novel products
thereof
    3.
    发明授权
    Process for the preparation of 17.alpha.-bromoethynyl- and 17.alpha.-iodoethynyl-17.beta.-hydroxy steroids and novel products thereof 失效
    制备17α-溴乙炔基 - 和17α-碘代乙炔基-ββ-羟基类固醇的方法及其新产物

    公开(公告)号:US4550100A

    公开(公告)日:1985-10-29

    申请号:US552537

    申请日:1983-11-16

    摘要: A process for preparing bromine- or iodine-unlabeled or radioactively labeled 17.alpha.-bromoethynyl- and 17.alpha.-iodoethynyl-17.beta.-hydroxy steroids of the androstane and estrane series of the partial formula ##STR1## wherein is a single bond or a double bond,V is a carbon-carbon bond or a methylene group,R is hydrogen or methyl, andX is bromine or iodine,from corresponding 17.alpha.-ethynyl-17.beta.-hydroxy steroids, comprises treating the starting steroid in an inert solvent with a brominating agent or an iodinating agent in the presence of a silver salt.The process enables production of old and new compounds having value as pharmacologically active compounds and also as diagnostic agents when the iodine or bromine is radioactive.

    摘要翻译: 制备溴或碘未标记或放射性标记的17α-溴乙炔基 - 和17α-碘代乙炔基-17β-羟基类固醇的方法,所述甾族化合物和部分分子式“IMAGE”的雌激素系列是单键或双重 键,V是碳 - 碳键或亚甲基,R是氢或甲基,X是溴或碘,来自相应的17α-乙炔基-17β-羟基类固醇,包括在惰性溶剂中处理起始类固醇, 溴化剂或碘化剂在银盐存在下进行。 该方法能够生产具有价值作为药理活性化合物的老化合物和新化合物,并且当碘或溴是放射性时也可以作为诊断剂。

    Novel pregnanoic acid derivatives
    9.
    发明授权
    Novel pregnanoic acid derivatives 失效
    新型孕酸衍生物

    公开(公告)号:US4049804A

    公开(公告)日:1977-09-20

    申请号:US668394

    申请日:1976-03-19

    摘要: Pregnanoic acid derivatives of general formula ##STR1## wherein is a single bond or a double bond; X is hydrogen, fluorine or methyl; Y is hydrogen, fluorine or chlorine; Z is .beta.-hydroxymethylene, .beta.-acyloxymethylene, .beta.-fluoromethylene, .beta.-chloromethylene, carbonyl or methylene; R.sub.1 is hydrogen, methyl in the .alpha.- or .beta.-position or methylene and R.sub.2 is hydrogen, hydroxy or acyloxy, or R.sub.1 and R.sub.2 collectively are alkylidendioxy and U.sub.1 is halogen, halogenated alkyl of 1-5 carbon atoms or halogenated phenyl, are topically effective anti-inflammatory agents.

    摘要翻译: 通式的孕酸衍生物,其中是单键或双键; X是氢,氟或甲基; Y是氢,氟或氯; Z是β-羟基亚甲基,β-酰氧基亚甲基,β-氟亚甲基,β-氯亚甲基,羰基或亚甲基; R1是氢,α或β-位中的甲基或亚甲基,R2是氢,羟基或酰氧基,或R1和R2共同是亚烷基二氧基,U1是卤素,1-5个碳原子的卤代烷基或卤代苯基是局部的 有效的抗炎剂。